Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
1-Year Return 34.48%
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
+16.97%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.78B
Cap. Flow %
-0.6%
Top 10 Hldgs %
22.42%
Holding
3,363
New
106
Increased
1,797
Reduced
1,249
Closed
100

Top Buys

1
MSFT icon
Microsoft
MSFT
$1.04B
2
AAPL icon
Apple
AAPL
$880M
3
MRK icon
Merck
MRK
$323M
4
MDT icon
Medtronic
MDT
$317M
5
AMZN icon
Amazon
AMZN
$314M

Sector Composition

1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.19%
5 Communication Services 9.82%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AGTC
3051
DELISTED
Applied Genetic Technologies Corporation
AGTC
$428K ﹤0.01%
104,751
+3,900
+4% +$15.9K
REV
3052
DELISTED
Revlon, Inc.
REV
$426K ﹤0.01%
35,879
-13,410
-27% -$159K
GNLN icon
3053
Greenlane Holdings
GNLN
$4.53M
0
-$186K
TARS icon
3054
Tarsus Pharmaceuticals
TARS
$2.43B
$417K ﹤0.01%
+10,088
New +$417K
ASPS icon
3055
Altisource Portfolio Solutions
ASPS
$124M
$415K ﹤0.01%
4,028
+54
+1% +$5.56K
GALT icon
3056
Galectin Therapeutics
GALT
$295M
$414K ﹤0.01%
184,851
+2,965
+2% +$6.64K
PVLA
3057
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
$414K ﹤0.01%
2,069
+22
+1% +$4.4K
OZON
3058
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$414K ﹤0.01%
+10,000
New +$414K
SBFG icon
3059
SB Financial Group
SBFG
$140M
$413K ﹤0.01%
23,693
+11,808
+99% +$206K
ARA
3060
DELISTED
American Renal Associates Holdings, Inc
ARA
$412K ﹤0.01%
59,590
-6,453
-10% -$44.6K
XCUR icon
3061
Exicure
XCUR
$30M
$407K ﹤0.01%
1,534
+44
+3% +$11.7K
GNPX icon
3062
Genprex
GNPX
$7.68M
$406K ﹤0.01%
2,442
+58
+2% +$9.64K
AIFU
3063
AIFU Inc. Class A Ordinary Share
AIFU
$82.9M
$404K ﹤0.01%
1,676
-400
-19% -$96.4K
MLP icon
3064
Maui Land & Pineapple Co
MLP
$335M
$394K ﹤0.01%
34,159
+1,180
+4% +$13.6K
IUSV icon
3065
iShares Core S&P US Value ETF
IUSV
$22B
$392K ﹤0.01%
+6,302
New +$392K
NH
3066
DELISTED
NantHealth, Inc
NH
$392K ﹤0.01%
8,097
+129
+2% +$6.25K
GSIT icon
3067
GSI Technology
GSIT
$85.2M
$390K ﹤0.01%
52,746
+16,394
+45% +$121K
NYMX
3068
DELISTED
Nymox Pharmaceutical Corp
NYMX
$390K ﹤0.01%
157,334
+1,839
+1% +$4.56K
GCI icon
3069
Gannett
GCI
$629M
$389K ﹤0.01%
115,916
-631,957
-85% -$2.12M
PAVM icon
3070
PAVmed
PAVM
$9.77M
$389K ﹤0.01%
12,238
-48
-0.4% -$1.53K
CRK icon
3071
Comstock Resources
CRK
$4.66B
$388K ﹤0.01%
88,804
-350
-0.4% -$1.53K
DYAI icon
3072
Dyadic International
DYAI
$32.9M
$384K ﹤0.01%
71,320
+3,082
+5% +$16.6K
WEYS icon
3073
Weyco Group
WEYS
$294M
$383K ﹤0.01%
24,175
+441
+2% +$6.99K
MMP
3074
DELISTED
Magellan Midstream Partners, L.P.
MMP
$381K ﹤0.01%
8,981
-1,037
-10% -$44K
TSHA icon
3075
Taysha Gene Therapies
TSHA
$917M
$378K ﹤0.01%
+14,228
New +$378K